Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) closed its last session at $0.788 with the change of +1.993%. The market capitalization of the company is $20.38M with an average Volume of 785.68 thousand shares. The stock currently has its 52-Week High range of $7.950 and 52-week low range of $0.750. The Price to Book (P/B) ratio stands at 0.645. The stock traded total quantity of 1.32 million shares.
Currently Tonix Pharmaceuticals Holding Corp. (TNXP) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “0″ Analysts”. “0” rated “Sell” for the company. “3” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $4.08 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $10.00 however minimum price target advised by analysts is $1.00. The Median price target for the stock is measured at $1.25.
Presently, Analysts decided consensus EPS estimate of $-0.34 for present quarter and one month ago projected EPS estimate was at $-0.37. If we take a look at back 3 month ago, consensus EPS estimate was $-0.53.
A current consensus EPS estimate for next quarter is at $-0.24 and 3 month ago EPS forecast was $-0.50. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.34.
For current fiscal year, most recent EPS estimate is set at $-1.70 based on Analyst consensus and three month ago consensus EPS opinions was at $-2.39. During period one month ago, consensus EPS forecast was decided at $-1.86.
A current consensus EPS projection for next fiscal year is observed at $-0.98 and one month ago consensus EPS forecast was at $-1.40. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-1.85 by analysts.
One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 0 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 3 said a “Buy Rating” and 0 announced “Overweight Rating”. 0 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.